A retrospective analysis of allogeneic stem cell transplantation for peripheral T-cell lymphoma
Patients with peripheral T-cell lymphomas (PTCL) have poor prognosis and responses to currently recommended treatments which are often not durable.
FDA grants priority review to second-line pembrolizumab for the treatment of R/R Hodgkin lymphoma
On July 9, 2020, the U.S. Food and Drug Administration (FDA) granted priority review to pembrolizumab as monotherapy for second-line treatment of adult...
" The Lymphoma Hub allows you to navigate the most relevant and up-to-date information in lymphoma and CLL. From recently published papers to on-site interviews, we aim to deliver valuable data to all physicians practicing hemato-oncology. "